Loading...
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
BACKGROUND: This is an update of the 2009 Cochrane overview and network meta‐analysis (NMA) of biologics for rheumatoid arthritis (RA). OBJECTIVES: To assess the benefits and harms of nine biologics (abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, rituximab, t...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2016
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068903/ https://ncbi.nlm.nih.gov/pubmed/27175934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012183 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|